Time to Infection With Malaria Parasites
NCT00322738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2558
Last updated 2019-02-01
Summary
This study will attempt to find out what effect mosquito insecticides have on the transmission of malaria in The Gambia. Eight hundred healthy men and women, aged 18 to 40 years, living in selected villages east of Farafenni town in The Gambia, West Africa will be screened for parasites. About 552 of these people are expected to be free of malaria and will form the study group. These people will participate in the study for 7 months and will be checked for the malaria-causing parasite every two weeks by finger prick blood sample.
Conditions
- Plasmodium Falciparum Malaria
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-06-07
- Primary Completion
- 2008-03-31
- Completion
- 2009-03-31
Countries
- The Gambia
Study Locations
More Related Trials
-
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
NCT03035305 ·Status: COMPLETED ·Phase: NA
-
Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, Guinea
NCT04969913 ·Status: COMPLETED
-
Early Childhood Malaria Prevention With Maloprim in The Gambia
NCT00294580 ·Status: COMPLETED ·Phase: PHASE4
-
Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
NCT02471378 ·Status: RECRUITING
-
Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease
NCT01319448 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Malaria Vaccine in Children in Mali
NCT00341250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children
NCT00738946 ·Status: COMPLETED ·Phase: NA
-
Folic Acid Supplementation in Gambian Primigravidae
NCT00120822 ·Status: COMPLETED ·Phase: PHASE3
-
Examination of Protective Factors Against Severe Malaria
NCT00342043 ·Status: COMPLETED
-
Age of Exposure and Immunity to Malaria in Infants
NCT00231452 ·Status: COMPLETED ·Phase: NA
-
Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali
NCT00669084 ·Status: COMPLETED
-
Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso
NCT04650815 ·Status: COMPLETED
-
A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children
NCT00132561 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fetal Immunity to Falciparum Malaria
NCT00314899 ·Status: COMPLETED
-
Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children
NCT00561899 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
NCT00111163 ·Status: COMPLETED ·Phase: NA
-
Correlates of Protection in Ghana
NCT00138307 ·Status: COMPLETED
-
Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
NCT04301531 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Rapid Diagnosis Tests in Imported Malaria
NCT00451269 ·Status: COMPLETED
-
Human Immunity to MSP-1 in Western Kenya
NCT00138372 ·Status: COMPLETED
-
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
NCT05354258 ·Status: UNKNOWN ·Phase: NA
-
Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
NCT02535767 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy
NCT00432367 ·Status: COMPLETED ·Phase: PHASE3
-
Malaria Transmission and Immunity in Highland Kenya
NCT00393757 ·Status: COMPLETED
-
Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in Mali
NCT00623155 ·Status: COMPLETED ·Phase: NA